ETA-DOC-0004·Compound index·Rev 1·Methodology v0.1Provisional — reviewer not yet appointed
compound index · T, page 3 of 4 · methodology v0.1 · reviewer not yet appointed
Compound index · T ETA-DOC-0004

Compound index — T

767 substances begin with T. 8 of them carry an Etalyn grade; the remainder are marked not yet graded, which is a statement about Etalyn’s coverage and not about the substance. This page shows 200 of them, Tiliae flos – Tricholoma magnivelare.

US-DRUGListed as a marketed drug substance in the United StatesEU-MEDActive substance in a centrally authorised EU medicineEU-HERBSubject of an EU herbal monographUS-CSAScheduled under the US Controlled Substances ActCA-NHPLicensed supplement ingredient in CanadaEU-CLAIMAppears in the EU nutrition and health claims registerEU-NOVELAppears in the EU novel food catalogueETALYNEtalyn has graded a claim about this substance
Tiliae flos EU-HERB Not yet graded
Herbal monograph: F: Assessment finalised
also: Lime flower; Tilia cordata Miller;Tilia platyphyllosScop.;Tilia x vulgaris Heyne
Class as recordedherbal: Cough and cold;Mental stress and mood disorders
Recorded fromEU-HERB — 1 of 7 registers
Etalyn identifierETA-C-014615
Tiliae tomentosae flos EU-HERB Not yet graded
Herbal monograph: F: Assessment finalised
also: Silver lime flower; Tilia tomentosa Moench
Recorded fromEU-HERB — 1 of 7 registers
Etalyn identifierETA-C-014616
Tilidine US-CSA Not yet graded
CSA Schedule Inarcotic
Class as recordedDEA: narcotic / opioid
DEA other namesTilidate; Valoron; Kitadol; Lak; Tilsa
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-014617
Tillandsia usneoides CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014618
Tilletia Caries US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Copper Absorption Inhibitor [EPC]; Decreased Copper Ion Absorption [PE]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014619
Tilleul CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014620
Tilmanocept EU-MEDUS-DRUG Not yet graded
EU medicine: WithdrawnUS: bulk ingredient for human prescription compounding
Class as recordedV09IA09
Market presence1 US product listings · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-014621
Tilmicosin US-DRUG Not yet graded
US: bulk ingredient
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014622
Tiludronate Disodium US-DRUG Not yet graded
Earliest US approval1997
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014623
Timolol EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Antagonists [MoA]; Carbonic Anhydrase Inhibitor [EPC]; Carbonic Anhydrase Inhibitors [MoA]
Earliest US approval1978
Market presence137 US product listings · 100 FDA applications · 2 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-014624
TIN CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: unapproved homeopathic
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Acidifying Activity [MoA]; Allergens [CS]
Market presence132 US product listings · 158 Canadian licensed products
Recorded fromCA-NHP, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-014625
Tin (II)-fluoride CA-NHP Not yet graded
CA licensed ingredient
Market presence11 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014626
Tin difluoride CA-NHP Not yet graded
CA licensed ingredient
Market presence6 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014627
TIN Monoarsenide US-DRUG Not yet graded
US: unapproved homeopathic
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014628
Tinidazole US-DRUG Not yet graded
US: anda
Class as recordedNitroimidazole Antimicrobial [EPC]; Nitroimidazoles [CS]
Earliest US approval2004
Market presence13 US product listings · 7 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014629
Tinospora cordifolia CA-NHPEU-NOVEL Not yet graded
Not novel in foodCA licensed ingredient
Market presence185 Canadian licensed products
Parts in scopeNon-concentrated aqueous infusion
Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers
Etalyn identifierETA-C-014630
Tinospora sagittata CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014631
Tinospora sinensis CA-NHP Not yet graded
CA licensed ingredient
Market presence24 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014632
Tinzaparin Sodium US-DRUG Not yet graded
Earliest US approval2000
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014633
Tioconazole US-DRUG Not yet graded
US: anda
Class as recordedAzole Antifungal [EPC]; Azoles [CS]
Earliest US approval1983
Market presence22 US product listings · 3 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014634
Tiomolibdate Diammonium US-DRUG Not yet graded
US: bulk ingredient
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014635
Tiopronin US-DRUG Not yet graded
US: anda
Class as recordedCystine Disulfide Reduction [MoA]; N-substituted Glycines [CS]; Reducing and Complexing Thiol [EPC]
Earliest US approval1988
Market presence22 US product listings · 9 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014636
Tiotropium Bromide US-DRUG Not yet graded
US: anda
Class as recordedAdrenergic beta2-Agonists [MoA]; Anticholinergic [EPC]; Cholinergic Antagonists [MoA]; beta2-Adrenergic Agonist [EPC]
Earliest US approval2004
Market presence16 US product listings · 5 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014637
Tiotropium Bromide Monomethanolate US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014638
Tioxolone US-DRUG Not yet graded
US: otc monograph final
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Food Additives [CS]
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014639
Tipiracil EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedL01BC59; Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Analog Antiviral [EPC]; Nucleoside Analog [EXT]
Earliest US approval2015
Market presence10 US product listings · 4 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-014640
Tipranavir EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedJ05AE09
Earliest US approval2005
Market presence2 US product listings · 3 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-014641
tiratricol EU-MED Not yet graded
EU medicine: Authorised
Class as recordedH03AA04
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-014642
Tirbanibulin EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedD06BX03; Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]
Earliest US approval2020
Market presence2 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-014643
Tirofiban Hydrochloride US-DRUG Not yet graded
US: anda
Class as recordedDecreased Platelet Aggregation [PE]; Platelet Aggregation Inhibitor [EPC]
Earliest US approval1998
Market presence13 US product listings · 5 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014644
Tirzepatide ETALYNEU-MEDUS-DRUG A/supportedband 1
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedA10BX16; G-Protein-linked Receptor Interactions [MoA]; GLP-1 Receptor Agonist [EPC]; Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
Earliest US approval2022
Market presence166 US product listings · 2 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-014645
Tisagenlecleucel EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedAutologous; CD19 Receptor Interactions [MoA]; CD19-directed Chimeric Antigen Receptor [EPC]; CD19-specific Chimeric Antigen Receptor [CS]
Market presence2 US product listings · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-014646
Tislelizumab EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, WithdrawnUS: bla
Class as recordedL01FF09; Programmed Death Receptor-1 Blocking Antibody [EPC]; Programmed Death Receptor-1-directed Antibody Interactions [MoA]
Market presence6 US product listings · 2 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-014647
Tislelizumab-Jsgr US-DRUG Not yet graded
Earliest US approval2024
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014648
Tisotumab US-DRUG Not yet graded
US: drug for further processing
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014649
Tisotumab Vedotin EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedL01FX23
Market presence4 US product listings · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-014650
Tisotumab Vedotin-Tftv US-DRUG Not yet graded
Earliest US approval2021
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014651
Titanium CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: unapproved homeopathic
Class as recordedAllergens [CS]; Amide Local Anesthetic [EPC]; Amides [CS]; Antiarrhythmic [EPC]
Market presence31 US product listings · 1 Canadian licensed products
Recorded fromCA-NHP, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-014652
Titanium Carbide US-DRUG Not yet graded
US: unapproved homeopathic
Market presence16 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014653
Titanium Dichloride US-DRUG Not yet graded
US: unapproved homeopathic
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014654
Titanium Dioxide CA-NHPEU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawnCA licensed ingredientUS: bulk ingredient
Class as recordedAcidifying Activity [MoA]; Adenosine Receptor Agonist [EPC]; Adenosine Receptor Agonists [MoA]; Adrenocorticotropic Hormone [CS]
Earliest US approval2006
Market presence2,939 US product listings · 2 FDA applications · 1 EU medicines · 1,111 Canadian licensed products
Recorded fromCA-NHP, EU-MED, US-DRUG — 3 of 7 registers
Etalyn identifierETA-C-014655
Titanium Disulfate US-DRUG Not yet graded
US: unapproved homeopathic
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014656
Titanium metallicum CA-NHP Not yet graded
CA licensed ingredient
Market presence19 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014657
Titanium Oxysulfate US-DRUG Not yet graded
US: unapproved homeopathic
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014658
Tividenofusp Alfa US-DRUG Not yet graded
US: bla
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014659
Tividenofusp Alfa-Eknm US-DRUG Not yet graded
Earliest US approval2026
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014660
Tivozanib EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedKinase Inhibitor [EPC]; L01EK03; Tyrosine Kinase Inhibitors [MoA]
Earliest US approval2021
Market presence9 US product listings · 2 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-014661
tixagevimab EU-MED Not yet graded
EU medicine: Withdrawn
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-014662
Tizanidine Hydrochloride US-DRUG Not yet graded
US: anda
Class as recordedAdrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]
Earliest US approval1996
Market presence212 US product listings · 32 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014663
TK-112690 US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014664
TL-895 US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014665
Tobacco Leaf US-DRUG Not yet graded
US: bla
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]
Market presence132 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014666
Tobacco Smoke US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Cell-mediated Immunity [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014667
Tobramycin EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, WithdrawnUS: anda
Class as recordedAminoglycoside Antibacterial [EPC]; Aminoglycosides [CS]; Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]
Earliest US approval1975
Market presence115 US product listings · 73 FDA applications · 3 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-014668
Tocainide Hydrochloride US-DRUG Not yet graded
Earliest US approval1984
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014669
toceranib EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Market presence1 US product listings · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-014670
Tocilizumab EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedInterleukin 6 Receptor Antagonists [MoA]; Interleukin-6 Receptor Antagonist [EPC]; L04AC07
Earliest US approval2010
Market presence33 US product listings · 2 FDA applications · 5 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-014671
Tocilizumab-Aazg US-DRUG Not yet graded
Earliest US approval2024
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014672
Tocilizumab-Anoh US-DRUG Not yet graded
Earliest US approval2025
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014673
Tocilizumab-Bavi US-DRUG Not yet graded
Earliest US approval2023
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014674
tocofersolan EU-MED Not yet graded
EU medicine: Authorised
Class as recordedA11HA08
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-014675
Tocopherol US-DRUG Not yet graded
US: otc monograph drug
Class as recordedAllergens [CS]; Ammonium Ion Binding Activity [MoA]; Analogs/Derivatives [Chemical/Ingredient]; Arteriolar Vasodilation [PE]
Earliest US approval2001
Market presence25 US product listings · 3 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014676
Tocopherol concentrate, mixed CA-NHP Not yet graded
CA licensed ingredient
Market presence62 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014677
Tocopherols concentrate-mixed CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014678
Tocopheryl Retinoate US-DRUG Not yet graded
US: otc monograph drug
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014679
Tocotrienol concentrate CA-NHP Not yet graded
CA licensed ingredient
Market presence104 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014680
Tocotrienols CA-NHP Not yet graded
CA licensed ingredient
Market presence216 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014681
Tofacitinib EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, RefusedUS: anda
Class as recordedJanus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]; L04AF01
Earliest US approval2012
Market presence80 US product listings · 31 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-014682
Tofersen EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: nda
Class as recordedAntisense Oligonucleotide [EPC]; Antisense [CS]; N07XX22; Oligonucleotides
Earliest US approval2023
Market presence1 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-014683
Tolazamide US-DRUG Not yet graded
Earliest US approval1966
Market presence31 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014684
Tolazoline Hydrochloride US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval1948
Market presence4 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014685
Tolbutamide US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval1957
Market presence3 US product listings · 18 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014686
Tolcapone EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedCatechol O-Methyltransferase Inhibitors [MoA]; Catechol-O-Methyltransferase Inhibitor [EPC]; N04BX01
Earliest US approval1998
Market presence6 US product listings · 5 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-014687
tolebrutinib EU-MED Not yet graded
EU medicine: Authorised
Class as recordedL04AA62
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-014688
tolfenamic acid EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-014689
Tolmetin Sodium US-DRUG Not yet graded
US: anda
Class as recordedAnti-Inflammatory Agents; Cyclooxygenase Inhibitors [MoA]; Non-Steroidal [CS]; Nonsteroidal Anti-inflammatory Drug [EPC]
Earliest US approval1976
Market presence7 US product listings · 16 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014690
Tolnaftate US-DRUG Not yet graded
US: bulk ingredient
Class as recordedCorticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]
Market presence338 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014691
Tolterodine US-DRUG Not yet graded
US: anda
Class as recordedCholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]
Earliest US approval1998
Market presence53 US product listings · 20 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014692
Toltrazuril EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Market presence4 US product listings · 3 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-014693
Toluene US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Estradiol Congeners [CS]; Estrogen Receptor Agonists [MoA]
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014694
Tolvaptan EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedC03XA01; Vasopressin V2 Receptor Antagonist [EPC]; Vasopressin V2 Receptor Antagonists [MoA]
Earliest US approval2009
Market presence36 US product listings · 11 FDA applications · 3 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-014695
Tomato CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: bla
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Bee Venoms [CS]
Market presence9 US product listings · 1 Canadian licensed products
Recorded fromCA-NHP, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-014696
Tomato Extract CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014697
Tomato extract containing lycopene EU-CLAIM Not yet graded
EU claims 0 authorised / 7 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Helps to maintain intact cells.”Non-authorisedArt.13(1)EFSA opinion
“Helps to maintain normal prostate health. Helps to maintain a healthy prostate.”Non-authorisedArt.13(1)EFSA opinion
“Can contribute to the maintenance of prostate health; Can contribute to the maintenance of the healthy function of prostate.”Non-authorisedArt.13(1)EFSA opinion
“Can contribute to the maintenance of skin health when exposed to sun.; Can help in the maintenance of healthy structure of the skin;”Non-authorisedArt.13(1)EFSA opinion
“Can help in the maintenance of the healthy function of the cardiovascular system.”Non-authorisedArt.13(1)EFSA opinion
“Contributes to the maintenance of a healthy cardiovascular system. Maintains cardiovascular health”Non-authorisedArt.13(1)EFSA opinion
“Helps to maintain healthy appearance and structure of the skin when exposed to sun. Helps protect the skin from exposure to sun.”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-014698
Tomato juice EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Tomato juice has a positive Influence on blood sugar level”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-014699
Tongo CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014700
Topiramate EU-MEDUS-DRUG Not yet graded
EU medicine: RefusedUS: anda
Class as recordedAppetite Suppression [PE]; Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]
Earliest US approval1996
Market presence373 US product listings · 60 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-014701
Topotecan EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawn, AuthorisedUS: anda
Class as recordedL01CE01; Topoisomerase Inhibitor [EPC]; Topoisomerase Inhibitors [MoA]
Earliest US approval1996
Market presence11 US product listings · 18 FDA applications · 7 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-014702
torasemide EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-014703
toremifene EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedEstrogen Agonist/Antagonist [EPC]; L02BA02; Selective Estrogen Receptor Modulators [MoA]
Earliest US approval1997
Market presence7 US product listings · 3 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-014704
Toripalimab EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedL01FF13; Programmed Death Receptor-1 Blocking Antibody [EPC]; Programmed Death Receptor-1-directed Antibody Interactions [MoA]
Market presence1 US product listings · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-014705
Toripalimab-Tpzi US-DRUG Not yet graded
Earliest US approval2023
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014706
Tormentilla CA-NHP Not yet graded
CA licensed ingredient
Market presence7 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014707
Tormentilla erecta CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014708
Tormentillae rhizoma EU-HERB Not yet graded
Herbal monograph: C: ongoing call for scientific data
also: Tormentil; Potentilla erecta (L.) Raeusch.
Class as recordedherbal: Mouth and throat disorders;Gastrointestinal disorders
Recorded fromEU-HERB — 1 of 7 registers
Etalyn identifierETA-C-014709
Torreya Grandis Seed US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014710
Torreya Nucifera Seed Oil US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014711
Torsemide US-DRUG Not yet graded
US: anda
Class as recordedIncreased Diuresis at Loop of Henle [PE]; Loop Diuretic [EPC]
Earliest US approval1993
Market presence78 US product listings · 15 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014712
Torula cerevisiae CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014713
Torula yeast (Cyberlindnera jadinii) biomass EU-NOVEL Not yet graded
Not novel in food
Parts in scopeWhole
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-014714
Torulaspora delbrueckii EU-NOVEL Not yet graded
Not novel in food
also: Candida colliculosa
Parts in scopeWhole
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-014715
Total saponin of Qing yang shen CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014716
Tovorafenib EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: nda
Class as recordedCytochrome P450 3A Inducers [MoA]; Kinase Inhibitor [EPC]; L01EC04; Type II RAF Kinase Inhibitors [MoA]
Earliest US approval2024
Market presence1 US product listings · 2 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-014717
Townsendia Exscapa Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Cell-mediated Immunity [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014718
Toxicodendron diversilobum CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014719
Toxicodendron Diversilobum Leaf US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Cell-mediated Immunity [PE]
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014720
Toxicodendron Diversilobum Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Food Additives [CS]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014721
Toxicodendron Pubescens Leaf US-DRUG Not yet graded
US: drug for further processing
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Acidifying Activity [MoA]; Actively Acquired Immunity [PE]
Market presence556 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014722
Toxicodendron Pubescens Shoot US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence10 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014723
Toxicodendron Pubescens Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Blood Coagulation Factor [EPC]; Calcium [CS]; Calculi Dissolution Agent [EPC]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014724
Toxicodendron quercifolium CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014725
Toxicodendron Radicans Leaf US-DRUG Not yet graded
US: drug for further processing
Class as recordedAllergens [CS]; Ammonium Ion Binding Activity [MoA]; Blood Coagulation Factor [EPC]; Calcium [CS]
Market presence7 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014726
Toxicodendron vernicifluum CA-NHP Not yet graded
CA licensed ingredient
Market presence7 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014727
Toxicodendron Vernix Leafy Twig US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Ammonium Ion Binding Activity [MoA]
Market presence19 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014728
Toxicophis pugnax CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014729
Toxoplasma Gondii CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: drug for further processing
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence10 US product listings · 3 Canadian licensed products
Recorded fromCA-NHP, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-014730
Toxoplasma Gondii DNA US-DRUG Not yet graded
US: drug for further processing
Market presence12 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014731
Tozorakimab US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014732
Trabectedin EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, RefusedUS: bulk ingredient
Class as recordedAlkylating Activity [MoA]; Alkylating Drug [EPC]; L01CX01
Earliest US approval2015
Market presence5 US product listings · 3 FDA applications · 2 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-014733
Trachelospermum jasminoides CA-NHP Not yet graded
CA licensed ingredient
Market presence11 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014734
Trachemys scripta elegans CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014735
Trachycarpus fortunei CA-NHP Not yet graded
CA licensed ingredient
Market presence27 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014736
Trachyspermum ammi CA-NHP Not yet graded
CA licensed ingredient
Market presence17 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014737
Trachyte CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014738
Tradescantia Occidentalis Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Standardized Chemical Allergen [EPC]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014739
Tradipitant US-DRUG Not yet graded
US: nda
Earliest US approval2025
Market presence1 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014740
Tragacanth CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Food Additives [CS]; Increased Histamine Release [PE]
Market presence2 US product listings · 5 Canadian licensed products
Recorded fromCA-NHP, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-014741
Tragopogon porrifolius EU-NOVEL Not yet graded
Not novel in food
also: Salsify; oyster plant; vegetable oyster; Tragopogon porrifolius f. porrifolius
Parts in scopeRoot
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-014742
Tralokinumab EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedD11; Interleukin-13 Antagonist [EPC]; Interleukin-13 Antagonists [MoA]
Earliest US approval2021
Market presence2 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-014743
Tralomethrin US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014744
Tramadol (2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol) US-CSA Not yet graded
CSA Schedule IVnarcotic
also: Tramadol methyl]-1- cyclohexanol)
Class as recordedDEA: narcotic / opioid
DEA other namesTramadol
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-014746
Tramadol Hydrochloride US-DRUG Not yet graded
US: anda
Class as recordedFull Opioid Agonists [MoA]; Opioid Agonist [EPC]
Earliest US approval1995
Market presence161 US product listings · 54 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014745
Trametes versicolor CA-NHPEU-NOVEL Not yet graded
Novel, not yet authorisedCA licensed ingredient
also: Boletus versicolor L., Poria versicolor (L.) Scop., Agaricus versicolor (L.) Lam., Boletus suberosus Batsch, Agarico-suber versicolor (L.) Paulet, Sistotrema versicolor (L.) Tratt., Polyporus versicolor (L.) Fr., Polystictus versicolor (L.) Fr., Hansenia versicolor (L.) P. Karst., Bjerkandera versicolor (L.) P. Karst., Microporus versicolor (L.) Kuntze, , Boletus atrofuscus Schaeff., Cellularia cyathiformis Bull., Boletus cyaneus Pers., Coriolus versicolor (L.) Quél., Polyporus fuscatus Fr., Polyporus nummularius Pers., Polyporus hirsutulus Schwein, Polyporus pectunculus Lév., Polyporus subflavus Lév., Polyporus apophysatus Rostk., Polystictus azureus Fr., Polyporus pictilis Berk., Polyporus nigricans Lasch, Polyporus cristulatus Speg., Polyporus caesioglaucus Cooke, Polystictus neaniscus Berk. ex Cooke, Polyporus antarcticus Speg., Polystictoides castaneicola Lázaro Ibiza, Polystictus corylicola Lázaro Ibiza, Polystictus inversus Lázaro Ibiza, Polystictoides castanicola Lázaro Ibiza, Polyporus luteovelutinus Bres., Polyporus carpineus Velen., Polyporus irpiciformis Velen., Polyporus picicola Velen., Polyporus reisneri Velen., Polyporus rohlenae Velen., Polyporus vitellinus Velen., Polyporus versicolor var. cyaneus Velen., Polyporus versicolor var. productus Velen., Polyporus versicolor var. rosiphilus Velen., Polystictus doidgeae Lloyd, Polystictus doidgei Lloyd
Market presence953 Canadian licensed products
Parts in scopeWhole
Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers
Etalyn identifierETA-C-014747
Trametinib EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedL01EE01
Earliest US approval2023
Market presence4 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-014748
Trametinib Dimethyl Sulfoxide EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedKinase Inhibitor [EPC]; L01EE01; Protein Kinase Inhibitors [MoA]
Earliest US approval2013
Market presence11 US product listings · 3 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-014749
Tramiprosate US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014750
Trandolapril US-DRUG Not yet graded
US: anda
Class as recordedAngiotensin Converting Enzyme Inhibitor [EPC]; Angiotensin-converting Enzyme Inhibitors [MoA]; Calcium Channel Antagonists [MoA]; Calcium Channel Blocker [EPC]
Earliest US approval1996
Market presence24 US product listings · 13 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014751
Tranexamic Acid US-DRUG Not yet graded
US: anda
Class as recordedAntifibrinolytic Agent [EPC]; Decreased Fibrinolysis [PE]
Earliest US approval1986
Market presence66 US product listings · 35 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014752
Tranexamic Acid Dimer US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014753
Tranilast US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014754
trans-3,4',5-Trihydroxystilbene CA-NHP Not yet graded
CA licensed ingredient
Market presence47 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014755
trans-Resveratrol CA-NHP Not yet graded
CA licensed ingredient
Market presence995 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014756
Transforming Growth Factor BETA-1 US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcidifying Activity [MoA]; Allergens [CS]; Anti-coagulant [EPC]; Bee Venoms [CS]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014757
Transgalactooligosaccharides CA-NHP Not yet graded
CA licensed ingredient
Market presence43 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014758
Transitech® EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Improve transit and durably regulates it”Non-authorisedArt.13(5)EFSA opinion
“Improves transit and durably regulates it.”Non-authorisedArt.13(5)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-014759
Tranylcypromine Sulfate US-DRUG Not yet graded
US: anda
Class as recordedMonoamine Oxidase Inhibitor [EPC]; Monoamine Oxidase Inhibitors [MoA]
Earliest US approval1961
Market presence7 US product listings · 4 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014760
Trapa Bicornis Seed US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Fruit Proteins [EXT]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014761
Trapa natans CA-NHPEU-NOVEL Not yet graded
Not novel in foodCA licensed ingredient
also: caltrops; Water chestnut; Trapa acicularis V.N.Vassil.
Market presence3 Canadian licensed products
Parts in scopeSeeds
Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers
Etalyn identifierETA-C-014762
Trastuzumab EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawn, AuthorisedUS: bla
Class as recordedEndoglycosidase [EPC]; Glycoside Hydrolases [CS]; HER2/Neu/cerbB2 Antagonists [MoA]; HER2/neu Receptor Antagonist [EPC]
Earliest US approval1998
Market presence20 US product listings · 1 FDA applications · 12 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-014763
Trastuzumab And Hyaluronidase-Oysk US-DRUG Not yet graded
Earliest US approval2019
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014764
Trastuzumab Deruxtecan EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedL01FD04
Market presence4 US product listings · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-014765
trastuzumab duocarmazine EU-MED Not yet graded
EU medicine: Application withdrawn
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-014766
Trastuzumab Emtansine EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedL01FD03
Market presence5 US product listings · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-014767
Trastuzumab-Anns US-DRUG Not yet graded
Earliest US approval2019
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014768
Trastuzumab-Dkst US-DRUG Not yet graded
Earliest US approval2017
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014769
Trastuzumab-Dttb US-DRUG Not yet graded
Earliest US approval2019
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014770
Trastuzumab-Pkrb US-DRUG Not yet graded
Earliest US approval2018
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014771
Trastuzumab-Qyyp US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval2019
Market presence1 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014772
Trastuzumab-Strf US-DRUG Not yet graded
US: bla
Class as recordedHER2/Neu/cerbB2 Antagonists [MoA]; HER2/neu Receptor Antagonist [EPC]
Earliest US approval2024
Market presence2 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014773
Travoprost EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedProstaglandin Analog [EPC]; Prostaglandins [CS]; S01ED51; S01EE04
Earliest US approval2001
Market presence31 US product listings · 14 FDA applications · 3 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-014774
Trazodone US-DRUG Not yet graded
US: anda
Class as recordedSerotonin Reuptake Inhibitor [EPC]
Earliest US approval1981
Market presence177 US product listings · 36 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014775
Tree hydrangea CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014776
Trehalose US-DRUG Not yet graded
US: bulk ingredient
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014777
Trehalose 6,6'-Dibehenate US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014778
Trelagliptin Succinate US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014779
Tremelimumab EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, WithdrawnUS: bla
Class as recordedCTLA-4-directed Antibody Interactions [MoA]; CTLA-4-directed Blocking Antibody [EPC]; Increased T Lymphocyte Activation [PE]; L01FX20
Market presence3 US product listings · 2 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-014780
Tremelimumab-Actl US-DRUG Not yet graded
Earliest US approval2022
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014781
Tremella fuciformis CA-NHPEU-NOVEL Not yet graded
Not novel in foodCA licensed ingredient
also: Snow fungus; Nakaiomyces nipponicus Kobayasi; Tremella nipponica (Kobayasi) Wojewoda
Market presence127 Canadian licensed products
Parts in scopeFruiting body; Mycelium
Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers
Etalyn identifierETA-C-014782
Tremella Fuciformis Whole US-DRUG Not yet graded
US: otc monograph drug
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014783
Trenbolone US-CSAUS-DRUG Not yet graded
CSA Schedule IIIUS: bulk ingredient
Class as recordedDEA: anabolic steroid
Market presence6 US product listings
DEA other namesFinaplix-S; Finajet; Parabolan
Recorded fromUS-CSA, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-014784
trenibotulinumtoxinE EU-MED Not yet graded
EU medicine: Authorised
Class as recordedNot yet assigned
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-014785
trenonacog alfa EU-MED Not yet graded
EU medicine: Application withdrawn
Class as recordedB02BD12
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-014786
Treosulfan EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: nda
Class as recordedL01AB02
Earliest US approval2025
Market presence2 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-014787
Treponema Denticola US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Copper Absorption Inhibitor [EPC]; Decreased Copper Ion Absorption [PE]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014788
Treponemic Skin Canker Human US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedActively Acquired Immunity [PE]; Allergens [CS]; Calculi Dissolution Agent [EPC]; Cell-mediated Immunity [PE]
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014789
Treprostinil EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawn, AuthorisedUS: anda
Class as recordedB01AC21; Prostacycline Vasodilator [EPC]; Prostaglandins I [CS]; Vasodilation [PE]
Earliest US approval2002
Market presence60 US product listings · 12 FDA applications · 2 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-014790
Treprostinil Hexadecyl Ester US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014791
Tretinoin US-DRUG Not yet graded
US: anda
Class as recordedCorticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]; Decreased Sebaceous Gland Activity [PE]; Depigmenting Activity [PE]
Earliest US approval1971
Market presence111 US product listings · 54 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014792
Triacylglycerol acylhydrolase CA-NHP Not yet graded
CA licensed ingredient
Market presence281 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014793
Triacylglycerol lipase CA-NHP Not yet graded
CA licensed ingredient
Market presence2,388 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014794
Triamcinolone US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval1957
Market presence4 US product listings · 19 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014795
Triamcinolone Acetonide US-DRUG Not yet graded
US: anda
Class as recordedCorticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]; Polyene Antifungal [EPC]; Polyenes [CS]
Earliest US approval1958
Market presence330 US product listings · 192 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014796
Triamcinolone Diacetate US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval1959
Market presence2 US product listings · 8 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014797
Triamcinolone Hexacetonide US-DRUG Not yet graded
US: bulk ingredient
Class as recordedCorticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]
Earliest US approval1969
Market presence3 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014798
Triamterene US-DRUG Not yet graded
US: anda
Class as recordedDecreased Renal K+ Excretion [PE]; Increased Diuresis [PE]; Potassium-sparing Diuretic [EPC]; Thiazide Diuretic [EPC]
Earliest US approval1964
Market presence82 US product listings · 28 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014799
Triazolam US-CSAUS-DRUG Not yet graded
CSA Schedule IVUS: anda
Class as recordedBenzodiazepine [EPC]; Benzodiazepines [CS]; DEA: depressant
Earliest US approval1982
Market presence17 US product listings · 7 FDA applications
DEA other namesHalcion
Recorded fromUS-CSA, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-014800
Tribasic Calcium Phosphate US-DRUG Not yet graded
US: bulk ingredient
Class as recordedAcidifying Activity [MoA]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]
Market presence306 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014801
Tribuli terrestris herba EU-HERB Not yet graded
Herbal monograph: F: Assessment finalised
also: Tribulus herb; Tribulus terrestrisL.
Class as recordedherbal: Urinary tract and gynaecology disorders
Recorded fromEU-HERB — 1 of 7 registers
Etalyn identifierETA-C-014802
Tribulus terrestris CA-NHPEU-NOVEL Not yet graded
Not novel in supplementsCA licensed ingredient
also: Tribulus lanuginosus L.
Market presence1,147 Canadian licensed products
Parts in scopeFruits and herbs
Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers
Etalyn identifierETA-C-014803
Tribulus Terrestris Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Amino Acid [EPC]; Amino Acids [CS]; Androgen Receptor Agonists [MoA]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014804
Tributyrin EU-NOVEL Not yet graded
Novel, not yet authorised
Parts in scopeSubstance
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-014805
Tricalcium phosphate CA-NHP Not yet graded
CA licensed ingredient
Market presence6 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014806
Trichilia catigua CA-NHP Not yet graded
CA licensed ingredient
Market presence13 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014807
Trichinella Spiralis US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedActively Acquired Immunity [PE]; Adenovirus [Chemical/Ingredient]; Allergens [CS]; Cell-mediated Immunity [PE]
Market presence6 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014808
Trichlormethiazide US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval1960
Market presence2 US product listings · 17 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014809
Trichloroethylene US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Antiseptic [EPC]; Calculi Dissolution Agent [EPC]; Cell-mediated Immunity [PE]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014810
Trichoderma Harzianum US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Fungal Proteins [CS]; Increased Histamine Release [PE]
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014811
Trichoderma Viride US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Fungal Proteins [CS]; Increased Histamine Release [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014812
Trichodermin US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014813
Tricholoma magnivelare CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014814